Literature DB >> 21536372

How to tell if a new marker improves prediction.

Carvell T Nguyen, Michael W Kattan.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21536372     DOI： 10.1016/j.eururo.2011.04.029

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  10 in total

1.  Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.

Authors:  Guru Sonpavde; Juliane Manitz; Chen Gao; Darren Tayama; Constanze Kaiser; Daniel Hennessy; Doris Makari; Ashok Gupta; Shaad Essa Abdullah; Guenter Niegisch; Jonathan E Rosenberg; Dean F Bajorin; Petros Grivas; Andrea B Apolo; Robert Dreicer; Noah M Hahn; Matthew D Galsky; Andrea Necchi; Sandy Srinivas; Thomas Powles; Toni K Choueiri; Gregory R Pond
Journal:  J Urol       Date:  2020-06-18       Impact factor: 7.450

2.  Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma.

Authors:  Guru Sonpavde; Gregory R Pond; Jonathan E Rosenberg; Dean F Bajorin; Toni K Choueiri; Andrea Necchi; Giuseppe Di Lorenzo; Joaquim Bellmunt
Journal:  J Urol       Date:  2015-08-17       Impact factor: 7.450

3.  Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer.

Authors:  Stacy Loeb; Sanghyuk S Shin; Dennis L Broyles; John T Wei; Martin Sanda; George Klee; Alan W Partin; Lori Sokoll; Daniel W Chan; Chris H Bangma; Ron H N van Schaik; Kevin M Slawin; Leonard S Marks; William J Catalona
Journal:  BJU Int       Date:  2016-11-22       Impact factor: 5.588

4.  Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).

Authors:  Andrea Necchi; Guru Sonpavde; Salvatore Lo Vullo; Daniele Giardiello; Aristotelis Bamias; Simon J Crabb; Lauren C Harshman; Joaquim Bellmunt; Ugo De Giorgi; Cora N Sternberg; Linda Cerbone; Sylvain Ladoire; Yu-Ning Wong; Evan Y Yu; Simon Chowdhury; Gunter Niegisch; Sandy Srinivas; Ulka N Vaishampayan; Sumanta K Pal; Neeraj Agarwal; Ajjai Alva; Jack Baniel; Ali-Reza Golshayan; Rafael Morales-Barrera; Daniel W Bowles; Matthew I Milowsky; Christine Theodore; Dominik R Berthold; Gedske Daugaard; Srikala S Sridhar; Thomas Powles; Jonathan E Rosenberg; Matthew D Galsky; Luigi Mariani
Journal:  Eur Urol       Date:  2016-10-08       Impact factor: 20.096

5.  Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials.

Authors:  Guru Sonpavde; Gregory R Pond; Ronan Fougeray; Toni K Choueiri; Angela Q Qu; David J Vaughn; Guenter Niegisch; Peter Albers; Nicholas D James; Yu-Ning Wong; Yoo-Joung Ko; Srikala S Sridhar; Matthew D Galsky; Daniel P Petrylak; Ulka N Vaishampayan; Awais Khan; Nicholas J Vogelzang; Tomasz M Beer; Walter M Stadler; Peter H O'Donnell; Cora N Sternberg; Jonathan E Rosenberg; Joaquim Bellmunt
Journal:  Eur Urol       Date:  2012-11-26       Impact factor: 20.096

6.  Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study.

Authors:  A Ingels; M Hew; F Algaba; O J de Boer; R J A van Moorselaar; S Horenblas; P Zondervan; J J M C H de la Rosette; M Pilar Laguna Pes
Journal:  World J Urol       Date:  2016-05-20       Impact factor: 4.226

7.  Establishment and validation of prognostic nomograms in first-line metastatic gastric cancer patients.

Authors:  Yukiya Narita; Shigenori Kadowaki; Isao Oze; Yosuke Kito; Takeshi Kawakami; Nozomu Machida; Hiroya Taniguchi; Takashi Ura; Masashi Ando; Seiji Ito; Masahiro Tajika; Yasushi Yatabe; Hirofumi Yasui; Kei Muro
Journal:  J Gastrointest Oncol       Date:  2018-02

8.  Improving risk assessment in schizophrenia: epidemiological investigation of criminal history factors.

Authors:  Katrina Witt; Paul Lichtenstein; Seena Fazel
Journal:  Br J Psychiatry       Date:  2015-02-05       Impact factor: 9.319

9.  A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort.

Authors:  Amirhossein Jalali; Robert W Foley; Robert M Maweni; Keefe Murphy; Dara J Lundon; Thomas Lynch; Richard Power; Frank O'Brien; Kieran J O'Malley; David J Galvin; Garrett C Durkan; T Brendan Murphy; R William Watson
Journal:  BMC Med Inform Decis Mak       Date:  2020-07-03       Impact factor: 2.796

10.  The prostate health index PHI predicts oncological outcome and biochemical recurrence after radical prostatectomy - analysis in 437 patients.

Authors:  Andreas Maxeiner; Ergin Kilic; Julia Matalon; Frank Friedersdorff; Kurt Miller; Klaus Jung; Carsten Stephan; Jonas Busch
Journal:  Oncotarget       Date:  2017-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.